Glucose-lowering therapies and cancer risk: The trials and tribulations of trials and observations

Diabetologia

Volumn 53, Issue 9, 2010, Pages 1823-1826

  Johnson, J A ^a   Yasui, Y ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cancer; Controlled trials; Glitazones; Malignancy; Metformin; Observational studies; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; PLACEBO; ROSIGLITAZONE; SULFONYLUREA; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT;

BLOOD GLUCOSE MONITORING; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG DOSE ESCALATION; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; RISK REDUCTION; TREATMENT RESPONSE; CHEMICALLY INDUCED; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS, TYPE 2; NEOPLASMS;

CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; NEOPLASMS; THIAZOLIDINEDIONES;

EID: 77955552231     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1780-2     Document Type: Note

References (26)

1. YX Yang S Hennessy JD Lewis 2004 Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients Gastroenterology 127 1044 1050 10.1053/j.gastro.2004.07.011 1:CAS:528:DC%2BD2cXpsVOitrg%3D 15480982 (Pubitemid 39345873)
2. JMM Evans LA Donnelly AM Emslie-Smith DR Alessi AD Morris 2005 Metformin and reduced risk of cancer in diabetic patients BMJ 330 1304 1305 10.1136/bmj.38415.708634.F7 15849206 (Pubitemid 40813563)
3. SL Bowker SR Majumdar P Veugelers JA Johnson 2006 Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin Diab Care 29 254 258 10.2337/diacare.29.02.06.dc05-1558
4. LG Hemkens U Grouven R Bender, et al. 2009 Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study Diabetologia 52 1732 1744 10.1007/s00125-009-1418-4 1:CAS:528: DC%2BD1MXpsFyrsL0%3D 19565214
5. HM Colhoun SDRN Epidemiology Group 2009 Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group Diabetologia 52 1755 1765 10.1007/s00125-009-1453-1 1:STN:280:DC%2BD1Mrktl2kuw%3D%3D 19603149 Erratum Diabetologia 52: 2469
6. JM Jonasson R Ljung M Talbäck B Haglund S Gudbjörnsdò ttir G Steineck 2009 Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden Diabetologia 52 1745 1754 10.1007/s00125-009-1444-2 1:STN:280:DC%2BD1MrktlygtQ%3D%3D 19588120
7. CJ Currie CD Poole EAM Gale 2009 The influence of glucose-lowering therapies on cancer risk in type 2 diabetes Diabetologia 52 1766 1777 10.1007/s00125-009-1440-6 1:CAS:528:DC%2BD1MXpsFyrsLo%3D 19572116
8. SK Garg IB Hirsch JS Skyler 2009 Insulin glargine and cancer-an unsubstantiated allegation Diab Technol Ther 29 473 476
9. SJ Pocock L Smeeth 2009 Insulin glargine and malignancy: an unwarranted alarm Lancet 374 511 513 10.1016/S0140-6736(09)61307-6 19616841
10. L Smeeth SJ Pocock 2009 Authors reply Lancet 374 1744 10.1016/S0140-6736(09)62019-5
11. BB Duncan MI Schmidt 2009 Metformin, cancer, alphabet soup and the role of epidemiology in etiologic research Diab Care 32 1748 1750 10.2337/dc09-1183
12. A Dejgaard H Lynggaard J Råstam M Krogsgaard Thomsen 2009 No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis Diabetologia 52 2507 2512 10.1007/s00125-009-1568-4 1:STN:280:DC%2BC3c%2Fjslemtw%3D%3D 19838665
13. PD Home P Lagarenne 2009 Combined randomised controlled trial experience of malignancies in studies using insulin glargine Diabetologia 52 2499 2506 10.1007/s00125-009-1530-5 1:CAS:528:DC%2BD1MXhsVWls7vK 19756478
14. Home PD, Kahn SE, Jones NP, Noronha D, Beck-Nielsen H, Viberti G, for the ADOPT Study Group and the RECORD Steering Committee (2010) Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT and RECORD clinical trials. Diabetologia (in press). doi: 10.1007/s00125-010- 1804-y
15. RECORD Study Team 2009 Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial Lancet 373 2125 2135 10.1016/S0140-6736(09)60953-3
16. SE Kahn SM Haffner MA Heise WH Herman RR Holman NP Jones BG Kravitz JM Lachin MC O'Neill B Zinman G Viberti ADOPT Study Group 2006 Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy N Engl J Med 355 23 2427 2443 10.1056/NEJMoa066224 1:CAS:528:DC%2BD28Xht12ntrzF 17145742 (Pubitemid 44903747)
17. UK Prospective Diabetes Group 1998 Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. UKPDS 34 Lancet 352 854 865 10.1016/S0140-6736(98)07037-8 (Pubitemid 28416719)
18. AB Hill 1965 The environment and disease: association or causation? Proc R Soc Med 58 295 300 1:STN:280:DyaF2M%2FovVCmsw%3D%3D 14283879
19. PROActive investigators 2005 Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROActive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomized controlled trial Lancet 366 1279 1289 10.1016/S0140-6736(05)67528-9 (Pubitemid 41416583)
20. MR Goldstein 2006 PROActive Study Lancet 367 23 10.1016/S0140-6736(06) 67910-5 16399141 (Pubitemid 43038655)
21. JA Dormandy on behalf of PROActive Writing Committee 2006 PROActive Study-authors' reply Lancet 367 26 27 10.1016/S0140-6736(06)67915-4 (Pubitemid 43038660)
22. HC Gerstein 2010 Does insulin therapy promote, reduce, or have a neutral effect on cancers? JAMA 303 446 447 10.1001/jama.2010.60 1:CAS:528: DC%2BC3cXhs1GgtLo%3D 20124540
23. SE Nissen 2010 Setting the RECORD straight JAMA 303 1194 1195 10.1001/jama.2010.333 1:CAS:528:DC%2BC3cXktVWiu7Y%3D 20332408
24. Clinical Trials Registry Website. Available from www.clinicaltrials.gov/ ct2/search, accessed 30 March 2010
25. A Laupacis M Mamdani 2004 Observational studies of treatment effectiveness: some cautions Ann Intern Med 140 923 924 1:CAS:528: DC%2BD2cXlt1Cmu7Y%3D 15172907
26. PN Papanikolaou GD Christidi JP Ioannidis 2006 Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies CMAJ 174 635 641 16505459